The reasons why people have such varied experiences has been unclear, though new research from the 23andMe genetic testing ...

Eli Lilly’s Foundayo weight-loss pill is now available in the U.S. following the Food and Drug Administration’s approval ...

Under the new priority voucher program (CNPV), the FDA has approved a new oral GLP-1 drug, Foundayo, offering an alternative ...

Apparel retailers could see an up to $13 billion annual boost in spending because of GLP-1 drugs, according to an estimate by ...

The reason some people on weight-loss jabs shed pounds more easily than others may be because of their DNA, scientists have ...

The US Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a ...

A doctor discusses common issues and questions around Foundayo, the oral obesity pill approved by the FDA this week.

Why do Ozempic and Zepbound work differently for everyone? A new study identifies genetic variants linked to GLP-1 weight loss and side effects.

People on Foundayo, the new GLP-1 weight loss pill from Eli Lilly, tend to feel full faster, and may experience nausea, ...

By Leah Douglas WASHINGTON, April 6 (Reuters) - Americans starting weight-loss medicines for the first time want lower cost ...

CNBC spoke with five U.S. patients who recently started the pill following its launch and have varying initial experiences ...

Harley Pasternak breaks down why carbs were never the problem — and how rethinking them could be the missing piece in ...